Literature DB >> 23479252

Laparoscopic TME with APPEAR (Anterior and Perineal PlanE for ultra-low Anterior Resection of the Rectum) technique for distal rectal cancer.

Saverio Di Palo1, Paola De Nardi, Damiano Chiari, Paolo Gazzetta, Carlo Staudacher.   

Abstract

BACKGROUND: Laparoscopic sphincter saving rectal resection for low rectal cancer is hampered by narrow pelvis and limitations of current stapling devices. The APPEAR (Anterior Perineal PlanE for Ultra-low Anterior Resection of the Rectum) was proposed by Williams et al. as an alternative to the abdominal-perineal resection to perform very low rectal resection and anastomosis through a perineal wound. We adapted the original technique to the laparoscopic approach, avoiding any other abdominal incision.
METHODS: Between December 2011 and April 2012, five patients (2 females; median age 72 years (range 60-78)) with rectal cancer not involving the sphincters underwent laparoscopic total mesorectal excision (TME) with APPEAR. Mean distance of the tumor from anal verge was 3.2 ± 1.1 cm (range 2-5).
RESULTS: All of the procedures were completed laparoscopically. All of the anastomoses were stapled, and a protective stoma was always constructed. The surgical specimens were retrieved from the perineal wound, and the stoma performed through one of the port sites, without any further abdominal incision. Mean operative time was 333 ± 47 min (range 295-405), postoperative stay 12 ± 5 days (range 6-17). Perineal wound infection was observed in three patients, two of whom also had anastomotic fistula, and was treated conservatively with prolonged suction drainage. Histological examination showed three pT3N+, one T2N0, and one complete response after neoadjuvant radiochemotherapy, with a mean distal clear margin of 1.27 ± 0.5 cm (range 0.5-1.7). After a median follow-up of 9 months (range 8-12), one stoma reversal has been performed and the patient is fully continent.
CONCLUSIONS: Our experience shows the feasibility of the APPEAR technique with laparoscopic TME, without any other abdominal incision. This technique offers advantage over the limitations of current laparoscopic stapling devices and their scanty maneuverability in the pelvis, allowing resection and anastomosis under direct vision, with adequate distal clearance, while sparing the anal sphincters.

Entities:  

Mesh:

Year:  2013        PMID: 23479252     DOI: 10.1007/s00464-013-2886-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  3 in total

1.  Factors affecting the difficulty of laparoscopic total mesorectal excision with double stapling technique anastomosis for low rectal cancer.

Authors:  Takashi Akiyoshi; Hiroya Kuroyanagi; Masatoshi Oya; Tsuyoshi Konishi; Meiki Fukuda; Yoshiya Fujimoto; Masashi Ueno; Satoshi Miyata; Toshiharu Yamaguchi
Journal:  Surgery       Date:  2009-06-09       Impact factor: 3.982

2.  Anterior Perineal PlanE for Ultra-low Anterior Resection of the Rectum (the APPEAR technique): a prospective clinical trial of a new procedure.

Authors:  Norman S Williams; Jamie Murphy; Charles H Knowles
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

3.  Anterior Perineal PlanE for Ultralow Anterior Resection of the Rectum (the APPEAR Technique): a video demonstration.

Authors:  Khalid A El-Gendy; Jamie Murphy; Narinder S Kullar; Christopher L H Chan; Norman S Williams
Journal:  Ann Surg Oncol       Date:  2009-12-29       Impact factor: 5.344

  3 in total
  3 in total

Review 1.  Current concepts in rectal cancer.

Authors:  James W Fleshman; Nathan Smallwood
Journal:  Clin Colon Rectal Surg       Date:  2015-03

2.  Low rectal cancer: Sphincter preserving techniques-selection of patients, techniques and outcomes.

Authors:  Nikoletta Dimitriou; Othon Michail; Dimitrios Moris; John Griniatsos
Journal:  World J Gastrointest Oncol       Date:  2015-07-15

3.  Laparoscopy-assisted posterior low anterior resection of rectal cancer.

Authors:  Hao Qu; Yan-Fu Du; Min-Zhe Li; Yu-Dong Zhang; Jian Shen
Journal:  BMC Gastroenterol       Date:  2014-09-12       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.